Phronesis Artificial Intelligence, Inc

Phronesis AI is revolutionizing small-molecule drug discovery through fully autonomous design of novel compounds—delivered in days rather than months. Our AI-powered LIME platform transforms raw protein structures (e.g, PDB files) into tailored, drug-like molecules by letting users define desired properties such as biological activity, synthetic cost, and drug-likeness: Creates novel, receptor-targeted molecules from just an active-site structure : Automatically generates detailed, cost-effective synthetic routes with confidence scores and precursor information phronesisai.com (): Supports machine-readable synthesis protocols and wet-lab testing through robotic automation—slashing development time, cost, and variability. ’ —from molecular design and retrosynthesis planning to seamless robotic execution—helping researchers accelerate discovery, reduce failure, and maintain full control of their data and IP.